These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 302168)

  • 21. Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease.
    Welch AM; Holda JH; Swanborg RH
    J Immunol; 1980 Jul; 125(1):186-9. PubMed ID: 6155396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of acute experimental allergic encephalomyelitis in guinea pigs by prior transfer of suboptimal numbers of EAE-effector cells: induction of chronic EAE in whole tissue-sensitized guinea pigs.
    Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1982 Feb; 128(2):635-8. PubMed ID: 6172501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of cyclophosphamide on antibody formation in the mouse.
    Willers JM; Sluis E
    Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of suppression of colchicine in experimental allergic encephalomyelitis].
    Tateyama M
    Hokkaido Igaku Zasshi; 1988 Jan; 63(1):72-9. PubMed ID: 2452125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recipient contributions to serial passive transfer of experimental allergic encephalomyelitis.
    Wegmann KW; Hinrichs DJ
    J Immunol; 1984 May; 132(5):2417-23. PubMed ID: 6201543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific, transient suppression of the immune response by HGG tolerant spleen cells. II. Effector cells and target cells.
    Doyle MV; Parks E; Weigle WO
    J Immunol; 1976 Oct; 117(4):1152-8. PubMed ID: 61992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease.
    Cua DJ; Hinton DR; Stohlman SA
    J Immunol; 1995 Oct; 155(8):4052-9. PubMed ID: 7561116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance.
    Tan LJ; Kennedy MK; Dal Canto MC; Miller SD
    J Immunol; 1991 Sep; 147(6):1797-802. PubMed ID: 1716280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.
    Lider O; Santos LM; Lee CS; Higgins PJ; Weiner HL
    J Immunol; 1989 Feb; 142(3):748-52. PubMed ID: 2464023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
    Killen JA; Swanborg RH
    J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of T cell lines and clones from SJL/J and (BALB/c x SJL/J)F1 mice specific for myelin basic protein.
    Trotter J; Sriram S; Rassenti L; Chou CH; Fritz RB; Steinman L
    J Immunol; 1985 Apr; 134(4):2322-7. PubMed ID: 2579139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the mechanism of specific immunological unresponsiveness. II. Immunological properties of lymphoid cells from normal, immunized and immunologically unresponsive mice transferred into lethally irradiated recipients.
    Tomazic V; Vitale B
    Z Immunitatsforsch Exp Klin Immunol; 1976 Mar; 151(1-2):22-31. PubMed ID: 134525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental autoimmune encephalomyelitis in the maturing central nervous system. Transfer of myelin basic protein-specific T line lymphocytes to neonatal Lewis rats.
    Umehara F; Qin YF; Goto M; Wekerle H; Meyermann R
    Lab Invest; 1990 Feb; 62(2):147-55. PubMed ID: 1689408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells.
    McCarron RM; Spatz M; Kempski O; Hogan RN; Muehl L; McFarlin DE
    J Immunol; 1986 Dec; 137(11):3428-35. PubMed ID: 2431034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of antigen specificity, class II major histocompatibility complex restriction, and in vivo behavior of myelin basic protein-specific T cell lines and clones derived from (BALB/c x SJL/J) mice.
    Trotter J; Zamvil SS; Steinman L
    J Immunol; 1987 Sep; 139(6):1834-9. PubMed ID: 2442257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for suppressor cells in Lewis rats' experimental allergic encephalomyelitis.
    Adda DH; Beraud E; Depieds R
    Eur J Immunol; 1977 Sep; 7(9):620-3. PubMed ID: 923633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental allergic encephalitis: study of cellular immunity during disease suppression.
    von Muller CS; Spitler LE; LeCocq J
    Eur J Immunol; 1978 Nov; 8(11):771-6. PubMed ID: 82509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute/relapsing experimental autoimmune encephalomyelitis: induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation.
    Karussis D; Vourka-Karussis U; Mizrachi-Koll R; Abramsky O
    Mult Scler; 1999 Feb; 5(1):17-21. PubMed ID: 10096098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on induction and control of cell-mediated autoimmunity. II. Prevention of induction and activity of autoreactive T cells by suppressor cells and by a suppressive serum factor.
    L'age-Stehr J; Diamantstein T
    Eur J Immunol; 1978 Sep; 8(9):624-8. PubMed ID: 309399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.